GE HealthCare Technologies (GEHC)
Health Care6 articles
Price chart
Why is GEHC moving today?
-1.1%GEHC is -1.1% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 7 hours ago
GE HealthCare Technologies (GEHC) overview
GE HealthCare makes medical-imaging and diagnostic equipment.
GEHC is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
GE HealthCare Technologies trades on the NasdaqGS under the ticker symbol GEHC. The most recent market data puts the share price at about $69.57. That is down 1.11% on the session. At that price the company is worth roughly $31.42B.
Over the past 52 weeks, GEHC has traded between $58.75 and $89.77. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 16.0. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns. GEHC also pays a dividend. It yields around 0.23% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 7 hours ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch GEHC
GEHC is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each GEHC story as it breaks, and tags it bullish, bearish or neutral.
What moves GEHC
- Earnings. GEHC reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from GEHC.
- Sector news. Health Care stocks often move together, so a rival's news can move GEHC too.
Market Mood
Latest GEHC news
GE HealthCare (GEHC) and Medtronic (MDT) Options Bets Recommend Decline
Analysts recommend options bets against GE HealthCare (GEHC) and Medtronic (MDT) due to an oversaturation of bullish positions. This shift suggests a potential reversal in the sentiment surrounding these stocks, indicating that a decline could be imminent. Investors have already made numerous bets that these stocks would rise, which may prompt a market correction. This recommendation matters for investors as it highlights a shift in market sentiment within the crowded healthcare sector.
Read More: GE HealthCare (GEHC) and Medtronic (MDT) Options Bets Recommend Decline
Biogen (BIIB), Vertiv, GE HealthCare Stocks Make Premarket Moves
Stocks of Biogen (BIIB), Vertiv, GE HealthCare, and Generac experienced notable movements in the premarket. Specific percentage changes and trading volumes are not provided, but their fluctuations can indicate investor sentiment ahead of the market opening. Monitoring these stocks can offer insights into market trends and possible reactions to upcoming earnings or news. Understanding these movements is crucial for investors to make informed decisions based on market performance.
Read More: Biogen (BIIB), Vertiv, GE HealthCare Stocks Make Premarket Moves
GE Healthcare (GEHC) CFO Purchases $200,585 in Company Stock
James Saccaro, CFO of GE Healthcare (GEHC), purchased $200,585 worth of company stock. This transaction highlights insider confidence in the company’s future performance. Insider buying can be an indication of positive sentiment regarding future stock movements, which may influence investor perception. The purchase took place at a time when GEHC's stock price is subject to market fluctuations, making such insider activity notable for potential investors.
Read More: GE Healthcare (GEHC) CFO Purchases $200,585 in Company Stock
GEHC Reports Q1 2026 Revenue of $5.1 Billion with 2.9% Growth
GE HealthCare Technologies (GEHC) reported Q1 2026 revenue of $5.1 billion, reflecting a 2.9% organic growth year over year. The company noted a record backlog of $21.8 billion and a book-to-bill ratio of 1.07x. However, management reduced full-year profit guidance due to $250 million in gross inflation and a supplier-related recall, adjusting EPS to between $4.80 and $5.00 while projecting free cash flow of approximately $1.6 billion. Additionally, revenue increased in EMEA and other regions, but U.S. growth experienced mid-single digits, and China revenue improved sequentially despite a year-over-year decline.
Read More: GEHC Reports Q1 2026 Revenue of $5.1 Billion with 2.9% Growth
Terri A. Sewell Sells Stake in GE Healthcare (GEHC) and Tapestry (TPR)
Representative Terri A. Sewell reported the sale of stocks in GE Healthcare Technologies (GEHC) and Tapestry (TPR). The disclosed transactions included selling a total of approximately 1,500 shares of GEHC and 3,000 shares of TPR. The sales were registered as part of routine portfolio management. Investor reaction may be influenced by these moves as they could signal a shift in confidence regarding the future performance of these companies.
Read More: Terri A. Sewell Sells Stake in GE Healthcare (GEHC) and Tapestry (TPR)
GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CT
On March 23, 2026, GE HealthCare Technologies Inc. (GEHC) obtained FDA 510(k) clearance for its Photonova Spectra, a next-generation photon-counting CT system. This system features Deep Silicon detector technology, which provides higher spatial and spectral resolution compared to conventional models. It can process data volumes up to 50 times greater than standard CT systems, supporting efficient workflows. Following this clearance, GEHC is preparing for full commercial availability in the U.S. market, addressing the increasing diagnostic demand.
Read More: GE HealthCare (GEHC) Receives FDA Clearance for Photonova Spectra CTMore Health Care stocks
Frequently asked questions
Is GE HealthCare Technologies in the S&P 500?
Yes. GE HealthCare Technologies trades as GEHC and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is GEHC in?
GEHC sits in the Health Care sector of the S&P 500.
Where can I find the latest GEHC news?
Right here. This page collects recent GEHC news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is GE HealthCare Technologies's stock price?
GEHC last traded at about $69.57. Prices move all through the session, so this is the latest quote rather than a live one.
What is GE HealthCare Technologies's market cap?
GEHC is worth roughly $31.42B. Market cap is the share price times the number of shares outstanding.
What is GEHC's P/E ratio?
GEHC trades at a trailing P/E ratio of about 16.0. The ratio compares the share price with earnings per share over the past year.